First reported case of late recurrence of pulmonary mucormycosis in a renal transplant recipient with poorly controlled diabetes mellitus
Abstract Pulmonary mucormycosis (PM) is a rare, life‐threatening fungal infection usually affecting immunocompromised patients. Its incidence is rising, with a recent outbreak associated with COVID‐19 co‐infection. Amphotericin B along with early surgery are considered the standard treatment. Recurr...
Enregistré dans:
Auteurs principaux: | Cheuk Cheung Derek Leung, Yu Hong Chan, Man Ying Ho, Ming Chiu Chan, Chun Hoi Chen, Chin Tong Kwok, Yiu Cheong Yeung |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/22b1036d9b5540348bb5a5ece3e32856 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
par: F. Yuan, et autres
Publié: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
par: Tonya N. Watkins, et autres
Publié: (2018) -
Systemic mucormycosis caused by Rhizopus microsporus in a captive bottlenose dolphin
par: Lingling Chang, et autres
Publié: (2021) -
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
par: Junyan Qu, et autres
Publié: (2021) -
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
par: Abdullah Alqarihi, et autres
Publié: (2020)